Does the "new philosophy" in predictive, preventive and personalised medicine require new ethics? [0.03%]
预测性、预防性及个性化医学的“新哲学”需要新的伦理规范吗？
Eugenijus Gefenas,Asta Cekanauskaite,Egle Tuzaite et al.
Eugenijus Gefenas et al.
This paper maps the ethical issues that arise in the context of personalised medicine. First, it highlights the ethical problems related to increased predictive power of modern diagnostic interventions. Such problems emerge because the abil...
Promoting predictive, preventive and personalised medicine: European event of global importance [0.03%]
推动预测、预防及个人化医学的发展：举世瞩目的欧洲活动
Olga Golubnitschaja,Charles Swanton,Romano Danesi et al.
Olga Golubnitschaja et al.
Ulrich Marc Becher,Vedat Tiyerili,Dirk Skowasch et al.
Ulrich Marc Becher et al.
Cardiac diseases are the leading cause of death and reach epidemic proportions with aging. Advanced heart disease results from an abrupt or progressive loss of contractile cardiomyocytes. Following percutaneous coronary intervention and rev...
Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome? [0.03%]
缺血性心脏病干细胞治疗心血管修复的预后因素及优化策略
Jens Kastrup
Jens Kastrup
Coronary artery disease is a growing problem worldwide. Early treatment with stabilizing drugs and revascularization by percutaneous coronary intervention or by-pass surgery has reduced the mortality significantly, but it is still the most ...
Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments [0.03%]
退行性瓣膜病和生物瓣膜：风险评估、预测诊断及个性化治疗
Kristina Yeghiazaryan,Dirk Skowasch,Gerhard Bauriedel et al.
Kristina Yeghiazaryan et al.
Aortic stenosis (AS) is the most frequent valvular heart disease. Severe AS results in concentric left ventricular hypertrophy, and ultimately, the heart dilates and fails. During a long period of time patients remain asymptomatic. In this ...
Obstructive sleep apnea: its prevention and screening may contribute to the prevention of hypertension, diabetes and cardiovascular diseases [0.03%]
阻塞性睡眠呼吸暂停的预防和筛查有助于预防高血压、糖尿病及心血管疾病
Takeshi Tanigawa
Takeshi Tanigawa
Relationships between obstructive sleep apnea and cardiovascular diseases have been reported by both clinical and epidemiological studies. To investigate whether nocturnal intermittent hypoxia (NIH), a surrogate marker for obstructive sleep...
Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? [0.03%]
糖代谢异常和血脂异常与心血管疾病的关系：日本人群队列研究的启示——个体化防治
Yoshihiro Kokubo
Yoshihiro Kokubo
Metabolic disorder is a modifiable risk factor for cardiovascular diseases (CVD), and lifestyle modification is the key to improving metabolic disorder. Diabetes mellitus has been shown to be a risk factor for coronary heart disease (CHD) a...
Adiposity and risk of cardiovascular diseases in Japan: secular trend, individual level associations and causal pathway - implications for the prevention of cardiovascular diseases in societies with rapid economic development [0.03%]
日本肥胖与心血管疾病风险的流行趋势及其关联和因果途径——对快速发展社会的心血管病预防的意义
Hiroshi Yatsuya,Kazumasa Yamagishi,Hiroyasu Iso
Hiroshi Yatsuya
In Japan, overweight/obesity in adults defined as a body mass index of 25 kg/m(2) or over has roughly doubled among middle-aged men over the past few decades. In parallel with a population rightward shift in the degree of obesity, the propo...
Epidemiology and prevention of hypertension in Japanese: how could Japan get longevity? [0.03%]
日本高血压的流行病学和预防：日本如何才能长命百岁？
Katsuyuki Miura
Katsuyuki Miura
Japan is one of the countries with the longest longevity in the world, and it was accomplished by a drastic decline in stroke mortality from 1960's. The decline in stroke mortality would be largely explained by a population-wide decreasing ...